Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.

Daniel Costa is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Costa is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Dr. Raymond Mak is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute.Dr. Mak received his undergraduate degree from Cornell University and medical degree from Harvard Medical School, trained at the Harvard Radiation Oncology Residency Program, and is board certified in Radiation Oncology.Dr. Mak has over 10 years of experience in radiation treatment of thoracic malignancies including lung cancer, mesothelioma, and thymomas, and in the clinical application of advanced radiation therapy techniques including stereotactic body radiation therapy.  He has applied stereotactic body radiation therapy for novel indications including the treatment of cardiac arrhythmias. He led the implementation of MR-guided radiation therapy and adaptive radiation therapy program at BWH/DFCI in 2019 and has expertise in these innovative new treatment approaches. His research interests focus on developing genomic and imaging biomarkers to predict radiation therapy response and toxicity for lung cancer patients, and applying artificial intelligence techniques to automate radiation therapy planning and improve patient care. He has expertise in developing new methods to reduce the risk of cardiac and pulmonary toxicity for patients receiving radiation therapy. Dr. Mak is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Jennifer Temel is an Oncologist in Boston, Massachusetts. Dr. Temel is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Transplant, and Gastrostomy.

Jessica Lin is an Oncologist in Boston, Massachusetts. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Narjust Florez is an Oncologist in Boston, Massachusetts. Dr. Florez has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Large-Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Lung Adenocarcinoma. Dr. Florez is currently accepting new patients.

Michael Rabin is an Oncologist in Boston, Massachusetts. Dr. Rabin is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Jacob Sands is an Oncologist in Boston, Massachusetts. Dr. Sands is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Ibiayi Dagogo-Jack is an Oncologist and a Hematologist Oncology provider in Boston, Massachusetts. Dr. Dagogo-Jack is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Dagogo-Jack is currently accepting new patients.

Geoffrey Oxnard is an Oncologist in Boston, Massachusetts. Dr. Oxnard is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy. Dr. Oxnard is currently accepting new patients.

Kathryn Huber is a Radiologist in Boston, Massachusetts. Dr. Huber is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Nasopharyngeal Carcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC).

Rupal Bhatt is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Bhatt is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Large-Cell Lung Carcinoma.

Joanne Jang is a Radiologist in Boston, Massachusetts. Dr. Jang has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, Vulvar Cancer, and Gastrostomy.

Mihir Parikh is an Internal Medicine provider in Boston, Massachusetts. Dr. Parikh has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Tracheobronchomalacia, Acquired Tracheomalacia, Pleurisy, Gastrostomy, and Advanced Bronchoscopy.

Meghan Shea is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Shea is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. Her top areas of expertise are Endometrial Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Small Cell Lung Cancer (SCLC).

Joseph Aronovitz is a Radiologist in Boston, Massachusetts. Dr. Aronovitz is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Dr. Hisashi Tsukada is a thoracic surgeon at Brigham and Women’s Hospital.  He is also an assistant professor in surgery at Harvard Medical School. He received his medical degree and a PhD in medicine from St. Marianna University School of Medicine (Kawasaki, Japan). He then completed a residency in surgery at Mitsui Memorial Hospital (Tokyo). His fellowships include thoracic surgery at St. Marianna University Hospital, thoracic surgery research at Beth Israel Deaconess Medical Center and interventional pulmonology at St. Elizabeth’s Medical Center.   Dr. Tsukada specializes in Interventional Pulmonology and his clinical interests concentrate on aligning his research investigations to disease processes he has observed in patients as a practicing thoracic surgeon for more than ten years in Japan. Dr. Tsukada started his service at Brigham and Women’s Hospital in October 2014. He has expanded the Interventional Pulmonology procedures up to 1,000 cases per year in 2023. Dr. Tsukada is research focuses on developing an artificial trachea for in vivo implantation and airway tissue regeneration. He has authored 30 peer-reviewed publications. Dr. Tsukada is fluent in Japanese. Dr. Tsukada is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Lymphofollicular Hyperplasia, Mesothelioma, Advanced Bronchoscopy, and Endoscopy.

Dr. Gerald Lawrence Weinhouse is the medical director of Respiratory Care Services and a physician at Brigham and Women’s Hospital (BWH). He is also an assistant professor of medicine at Harvard Medical School .He received his medical degree from the University of Medicine and Dentistry of New Jersey (now part of Rutgers Biomedical and Health Sciences). He then completed a residency in internal medicine at Boston City Hospital (now Boston Medical Center), followed by fellowships in pulmonary disease at Boston University Medical Center (now Boston Medical Center) and University of Pennsylvania School of Medicine (now the Perelman School of Medicine ). He is board certified in general pulmonary medicine and lung cancer.Dr. Weinhouse’s clinical interests include lung cancer and general pulmonary medicine. A National Institutes of Health-funded investigator, he has authored over 20 peer-reviewed publications examining a variety of pulmonary and critical care-related issues. His research specifically studies the role of sleep in the recovery of intensive care unit patients. Dr. Weinhouse has been listed as one of the region’s top doctors by Castle Connolly. Dr. Weinhouse is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Bronchiolitis Obliterans, Chronic Graft Versus Host Disease (cGvHD), Acute Interstitial Pneumonia, and Small Cell Lung Cancer (SCLC).

Kwok Wong is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Triple-Negative Breast Cancer, Squamous Cell Lung Carcinoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).